Novo Nordisk Sues Hims & Hers Over Ozempic Copycat Drug

Is Hims & Hers selling dangerous knock-off drugs or is Big Pharma crushing affordable health care access?

Published FEB 11

Novo Nordisk Sues Hims & Hers Over Ozempic Copycat Drug

story

Above: Wegovy semaglutide tablets with injectable prescription weight loss medicines, Ozempic and Wegovy. Image credit: Michael Siluk/UCG/Universal Images Group/Getty Images

The Spin

Narrative A

Hims & Hers is flooding the market with dangerous knock-off drugs that contain impurities up to 86%, risking anaphylactic shock and hospitalizations while deceiving patients about safety. These unapproved compounded products evade FDA review and threaten lives when authentic, fully-stocked FDA-approved medications are readily available nationwide. Legal action is essential to stop this mass marketing scheme that prioritizes profits over patient safety.

Novo Nordisk

Narrative B

A Danish pharmaceutical giant is weaponizing the courts to crush affordable health care access for millions of Americans who depend on compounded medications. This lawsuit attacks the entire practice of pharmacy compounding, a vital component of personalized care that has safely served patients for decades. Big Pharma wants to eliminate consumer choice and force Americans into overpriced options, undermining competition and threatening patient-centered care.

Hims & Hers Comms on X